Skip to main content Accessibility help
×
Hostname: page-component-5c6d5d7d68-sv6ng Total loading time: 0 Render date: 2024-08-07T02:32:47.533Z Has data issue: false hasContentIssue false

Dictionary

Published online by Cambridge University Press:  03 July 2022

Runjan Chetty
Affiliation:
University of Toronto
Kumarasen Cooper
Affiliation:
University of Pennsylvania
Carol Cheung
Affiliation:
University of Toronto
Srinivas Mandavilli
Affiliation:
Hartford Hospital
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Selected references

Chang, A, Amin, A, Gabrielson, E, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012;36:1472–6.CrossRefGoogle ScholarPubMed
Ellis, CL, Chang, AG, Cimino-Mathews, A, et al. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. Am J Surg Pathol 2013;37:1756–60.CrossRefGoogle ScholarPubMed
Liu, H, Shi, J, Prichard, JW, et al. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol 2014;141:648–55.CrossRefGoogle ScholarPubMed
Liu, H, Shi, J, Wilkerson, ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: A useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012;138:5764.Google Scholar
Ordonez, NG. Value of GATA3 immunostaining in tumor diagnosis: A review. Adv Anat Pathol 2013;20:352–60.Google Scholar
Simon, MC. Gotta have GATA. Nat Genet 1995;11:911.CrossRefGoogle ScholarPubMed
Yoon, NK, Maresh, EL, Shen, D, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol 2010;41:1794–801.CrossRefGoogle ScholarPubMed

Selected references

Inagaki, M, Nakamura, Y, Takeda, M, et al. Glial fibrillary acidic protein: Dynamic property and regulation by phosphorylation. Brain Pathol 1994;4:239–43.Google Scholar

Selected references

Haber, RS, Weiser, KR, Pritsker, A, et al. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 1997;7:363–7.Google Scholar
Lyons, LL, North, PE, Mac-Moune Lai, F, et al. Kaposiform hemangioendothelioma: A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28:559–68.CrossRefGoogle ScholarPubMed
Mentzel, T, Kutzner, H. Reticular and plexiform perineurioma: Clinicopathological and immunohistochemical analysis of two cases and review of perineurial neoplasms of skin and soft tissues. Virchows Arch 2005;447:677–82.CrossRefGoogle ScholarPubMed

Selected references

Capurro, MI, Xiang, YY, Lobe, C, et al. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005;65:6245–54.Google Scholar
Capurro, M, Wanless, IR, Sherman, M, et al. Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003;125:8997.Google Scholar
Ou-Yang, RJ, Hui, P, Yang, XJ, et al. Expression of glypican 3 in placental site trophoblastic tumor. Diagn Pathol 2010;5:64.Google Scholar
Shafizadeh, N, Kakar, S. Diagnosis of well-differentiated hepatocellular lesions: Role of immunohistochemistry and other ancillary techniques. Adv Anat Pathol 2011;18:438–45.Google Scholar
Maeda, D, Ota, S, Takazawa, Y, et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol 2009;22:824–32.Google Scholar
Ushiku, T, Uozaki, H, Shinozaki, A, et al. Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci 2009;100:626–32.Google Scholar

Selected references

Fiel, MI, Cernainu, G, Burstein, DE, et al. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol 1996;40:637–41.CrossRefGoogle ScholarPubMed
Haagensen, DE Jr, Dilley, WG, Mazoujian, G, et al. Review of GCDFP-15: An apocrine marker protein. Ann N Y Acad Sci 1990;586:161–73.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×